Birch Hill tops up second tranche of Spectral Diagnostics financing
Canadian mid-market private equity firm Birch Hill Equity Partners has acquired additional shares in Spectral Medical Inc (TSX: EDT), a developer of treatments for endotoxemic septic shock. The purchase increases the second tranche of a previously announced company financing to $6.1 million. Birch Hill and another investor, Japanese manufacturer Toray Industries Inc, are helping finance the commercialization of Spectral Medical's lead product candidate. Founded in 1991, the company has its headquarters in Toronto.
30 March 2015•4 mins read
